Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Megalestari Epack Sentosaraya Tbk. (EPAC) vs Indofarma Tbk. (INAF)

Megalestari Epack Sentosaraya Tbk.Trading
Indofarma Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Megalestari Epack Sentosaraya Tbk. dan Indofarma Tbk.: Megalestari Epack Sentosaraya Tbk. diperdagangkan di Rp55 (kapitalisasi pasar 181,69 M, volume 24 jam 23,97 jt), sedangkan Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M). Perbedaan utamanya: Indofarma Tbk. jauh lebih besar — sekitar 2,1× kapitalisasi pasar Megalestari Epack Sentosaraya Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

EPACINAF
Kapitalisasi Pasar
181,69 M390,51 M
Volume
23,97 jt
Lot
239,69 rb
Perputaran
1,29 M
Harga Rata-rata
53,97
Nilai Transaksi
1,29 M
Harga Ekuilibrium Indikatif
55
Volume Ekuilibrium Indikatif
3,42 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

EPAC
Lihat detail
INAF
Lihat detail

Tentang Megalestari Epack Sentosaraya Tbk.

PT Megalestari Epack Sentosaraya Tbk ("Company") formerly PT Era Prima Adi Cipta Kreasindo and its subsidiaries (together the "Group") was established based on the Deed No.55, dated June 18, 2013 of Poppie Savitri Martosuhardjo Pharmanto, S.H., notary in Jakarta.

Selengkapnya di halaman EPAC

Tentang Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Selengkapnya di halaman INAF